Abdera Therapeutics | ApexOnco - Clinical Trials news and analysis

x

“OncologyPipeline is my favorite CI tool”

Head of Market Insights Oncology Europe

Daiichi Sankyo

Click here for more information

Data insights

18 December 2024

Conjugates enter their first clinical trials

Two Kelun ADCs and two actinium-based radioconjugates start phase 1.

Subscribe to Abdera Therapeutics